Literature DB >> 20675076

Association between pulmonary uptake of fluorodeoxyglucose detected by positron emission tomography scanning after radiation therapy for non-small-cell lung cancer and radiation pneumonitis.

Michael P Mac Manus1, Zhe Ding, Annette Hogg, Alan Herschtal, David Binns, David L Ball, Rodney J Hicks.   

Abstract

PURPOSE: To study the relationship between fluorodeoxyglucose (FDG) uptake in pulmonary tissue after radical radiation therapy (RT) and the presence and severity of radiation pneumonitis. METHODS AND MATERIALS: In 88 consecutive patients, (18)F-FDG-positron emission tomography was performed at a median of 70 days after completion of RT. Patients received 60 Gy in 30 fractions, and all but 15 had concurrent platinum-based chemotherapy. RT-induced pulmonary inflammatory changes occurring within the radiation treatment volume were scored, using a visual (0 to 3) radiotoxicity grading scale, by an observer blinded to the presence or absence of clinical radiation pneumonitis. Radiation pneumonitis was retrospectively graded using the Radiation Therapy Oncology Group (RTOG) scale by an observer blinded to the PET radiotoxicity score.
RESULTS: There was a significant association between the worst RTOG pneumonitis grade occurring at any time after RT and the positron emission tomograph (PET) radiotoxicity grade (one-sided p = 0.033). The worst RTOG pneumonitis grade occurring after the PET scan was also associated with the PET radiotoxicity grade (one-sided p = 0.035). For every one-level increase in the PET toxicity scale, the risk of a higher RTOG radiation pneumonitis score increased by approximately 40%. The PET radiotoxicity score showed no significant correlation with the duration of radiation pneumonitis.
CONCLUSIONS: The intensity of FDG uptake in pulmonary tissue after RT determined using a simple visual scoring system showed significant correlation with the presence and severity of radiation pneumonitis. (18)F-FDG-PET may be useful in the prediction, diagnosis and therapeutic monitoring of radiation pneumonitis.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20675076     DOI: 10.1016/j.ijrobp.2010.04.021

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  18 in total

1.  Early assessment of dosimetric and biological differences of total marrow irradiation versus total body irradiation in rodents.

Authors:  Susanta Hui; Yutaka Takahashi; Shernan G Holtan; Rezvan Azimi; Davis Seelig; Masashi Yagi; Jessie Ingvalson; Parham Alaei; Leslie Sharkey; Behiye Kodal; Nicholas Peterson; Carolyn Meyer; Lindsey Godin; Michael Ehrhardt; Guy Storme; Daohong Zhou; Angela Panoskaltsis-Mortari
Journal:  Radiother Oncol       Date:  2017-08-01       Impact factor: 6.280

2.  Multimodality molecular imaging of the lung.

Authors:  Delphine L Chen; Paul E Kinahan
Journal:  Clin Transl Imaging       Date:  2014-10-16

Review 3.  Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization.

Authors:  Michael MacManus; Sarah Everitt; Tanja Schimek-Jasch; X Allen Li; Ursula Nestle; Feng-Ming Spring Kong
Journal:  Transl Lung Cancer Res       Date:  2017-12

4.  Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial.

Authors:  Mitchell Machtay; Fenghai Duan; Barry A Siegel; Bradley S Snyder; Jeremy J Gorelick; Janet S Reddin; Reginald Munden; Douglas W Johnson; Larry H Wilf; Albert DeNittis; Nancy Sherwin; Kwan Ho Cho; Seok-Ki Kim; Gregory Videtic; Donald R Neumann; Ritsuko Komaki; Homer Macapinlac; Jeffrey D Bradley; Abass Alavi
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

Review 5.  PET in the management of locally advanced and metastatic NSCLC.

Authors:  Willem Grootjans; Lioe-Fee de Geus-Oei; Esther G C Troost; Eric P Visser; Wim J G Oyen; Johan Bussink
Journal:  Nat Rev Clin Oncol       Date:  2015-04-28       Impact factor: 66.675

6.  Patient-reported lung symptoms as an early signal of impending radiation pneumonitis in patients with non-small cell lung cancer treated with chemoradiation: an observational study.

Authors:  Jinbo Yue; Qiuling Shi; Ting Xu; Melenda Jeter; Ting-Yu Chen; Ritsuko Komaki; Daniel R Gomez; Tinsu Pan; Charles S Cleeland; Zhongxing Liao; Xin Shelley Wang
Journal:  Qual Life Res       Date:  2018-03-16       Impact factor: 4.147

Review 7.  Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis.

Authors:  Sugama Chicklore; Vicky Goh; Musib Siddique; Arunabha Roy; Paul K Marsden; Gary J R Cook
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-13       Impact factor: 9.236

8.  (18)F-Fluorodeoxyglucose Positron Emission Tomography Can Quantify and Predict Esophageal Injury During Radiation Therapy.

Authors:  Joshua S Niedzielski; Jinzhong Yang; Zhongxing Liao; Daniel R Gomez; Francesco Stingo; Radhe Mohan; Mary K Martel; Tina M Briere; Laurence E Court
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-07-21       Impact factor: 7.038

9.  Quantitative assessment of global lung inflammation following radiation therapy using FDG PET/CT: a pilot study.

Authors:  Sarah Abdulla; Ali Salavati; Babak Saboury; Sandip Basu; Drew A Torigian; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-10-02       Impact factor: 9.236

10.  A prospective study of the feasibility of FDG-PET/CT imaging to quantify radiation-induced lung inflammation in locally advanced non-small cell lung cancer patients receiving proton or photon radiotherapy.

Authors:  Pegah Jahangiri; Kamyar Pournazari; Drew A Torigian; Thomas J Werner; Samuel Swisher-McClure; Charles B Simone; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-18       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.